NASDAQ: RNA - Avidity Biosciences, Inc.

Rentabilidade por seis meses: +97.88%
Setor: Healthcare

Cronograma de promoção Avidity Biosciences, Inc.


Sobre a empresa

Avidity Biosciences, Inc., биофармацевтическая компания, занимается разработкой методов лечения на основе олигонуклеотидов. Компания разрабатывает конъюгаты олигонуклеотидов антител (АОС), предназначенные для лечения ряда серьезных заболеваний. Ведущий продукт компании AOC 1001 для лечения миотонической дистрофии 1 типа, редкого моногенного заболевания мышц, находится на стадии 1/2 клинических испытаний.

Mais detalhes
Другие продукты компании, находящиеся в стадии разработки, включают AOC 1044 для лечения мышечной дистрофии Дюшенна, который находится на стадии 1/2 клинических испытаний; и AOC 1020 для лечения лице-лопаточно-плечевой мышечной дистрофии находится на стадии 1/2 клинических испытаний. Компания Avidity Biosciences, Inc. была зарегистрирована в 2012 году и имеет штаб-квартиру в Сан-Диего, штат Калифорния.


Выручка 0.0023
EBITDA -0.017
P/S 87.49
EV/EBITDA 5.28
Цена ао 44.24
P/BV 1.94
Сайт https://www.aviditybiosciences.com
ISIN US05370A1088
Число акций ао 0.07301 млрд
Валюта usd
IPO date 2013-06-28
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Alteração de preço por dia: 0% (46.6)
Alteração de preço por semana: +6.03% (43.95)
Alteração de preço por mês: +11.72% (41.71)
Alteração de preço em 3 meses: -0.1714% (46.68)
Mudança de preço em seis meses: +97.88% (23.55)
Mudança de preço por ano: +654.05% (6.18)
Mudança de preço em 3 anos: +108.22% (22.38)
Mudança de preço desde o início do ano: +680.57% (5.97)

Subestimação

Nome Significado Nota
P/S 71.56 1
P/BV 1.37 9
P/E 0 0
EV/EBITDA -2.18 0
Total: 3.88

Eficiência

Nome Significado Nota
ROA, % -33.76 0
ROE, % -42.38 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.0422 10
Total: 9.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 312.25 10
Rentabilidade Ebitda, % 1274.81 10
Rentabilidade EPS, % 142.9 10
Total: 8

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
Invesco Dorsey Wright Healthcare Momentum ETF 2.48069 43.183192261185 0.12263
Global X Genomics & Biotechnology ETF 5.56148 2.5824964131994 0.15585
Avantis U.S. Equity ETF 0.01412 30.365392144069 1.59151
Virtus LifeSci Biotech Clinical Trials ETF 0.88098 63.040315712071 0.33
ProShares Ultra Nasdaq Biotechnology 0.28357 51.697637072723 0.85651
BNY Mellon US Small Cap Core Equity ETF 0.19555 30.067895247333 1.75333
Dimensional U.S. Core Equity 2 ETF 0.02018 30.755198832543 1.47098
Dimensional U.S. Targeted Value ETF 0.00811 26.007247921552 1.93487
Dimensional US Core Equity Market ETF 0.00622 30.983243755928 1.40618
Dimensional U.S. Equity ETF 0.00377 31.530984204131 1.3557
Invesco Dorsey Wright SmallCap Momentum ETF 0.83485 33.912466843501 0.61241
iShares ESG Aware MSCI USA Small-Cap ETF 0.08008 31.110458284371 1.49366
Fidelity MSCI Health Care Index ETF 0.04986 16.20294599018 1.46057
First Trust US Equity Opportunities ETF 0.22662 -95.311633281972 0.69524
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.06743 31.359936575053 1.41955
ProShares Hedge Replication ETF 0.0295 5.9237999659878 1.47892
Humankind US Stock ETF 0.01032 18.809430395549 1.99919
Invesco Nasdaq Biotechnology ETF 0.42096 28.578975171685 0.8565
iShares Russell 2000 Growth ETF 0.35512 38.042556988 0.6026
iShares Russell 3000 ETF 0.00863 31.230028873917 1.43482
John Hancock Multifactor Small Cap ETF 0.4895 29.343594166631 1.54912
SPDR S&P Kensho New Economies Composite ETF 0.11578 28.602833414753 0.88486
Direxion Daily S&P Biotech Bull 3x Shares 0.41114 4067.9190751445 0.25924
First Trust Multi-Manager Small Cap Opportunities ETF 0.2438 48.514285714286 0.31756
Nuveen ESG Small-Cap ETF 0.27222 27.987510644337 1.41019
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.07777 32.025164769323 1.75869
Schwab U.S. Small-Cap ETF 0.11661 -34.641922436355 1.51433
Schwab U.S. Broad Market ETF 0.00804 -56.193181818182 1.43354
SPDR Portfolio MSCI Global Stock Market ETF 0.00867 23.658352229781 2.19607
ProShares UltraPro Russell2000 0.10372 89.821266282945 1.47873
Vanguard U.S. Momentum Factor ETF 0.17 45.845704753962 1.05834
Vanguard Russell 3000 ETF 0.01 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.35 37.361289927043 0.60264
Vanguard Russell 2000 ETF 0.18 32.773459189339 1.48801
Vanguard Extended Market ETF 0.06 33.889077917659 1.34786
Principal Healthcare Innovators ETF 0.50542 618.4964157054 0.8416
Future Tech ETF 0.50542 426.33969118983 0.8416



Supervisor Cargo Pagamento Ano de nascimento
Dr. Troy Edward Wilson J.D., Ph.D. Co-Founder & Independent Chairman 67.5k 1969 (55 anos)
Ms. Sarah Boyce President, CEO & Director 1.05M 1972 (52 ano)
Mr. Michael F. MacLean Chief Financial & Chief Business Officer 701.64k 1966 (58 anos)
Ms. Teresa McCarthy Chief Human Resources Officer 665.14k 1964 (60 anos)
Dr. Frank P. McCormick Ph.D. Scientific Founder & Member of Scientific Advisory Board N/A 1950 (74 ano)
Mr. Eric B. Mosbrooker Chief Strategy Officer 42.5k 1967 (57 anos)
Dr. W. Michael F. Flanagan Ph.D. Chief Scientific & Technical Officer 1963 (61 ano)
Dr. Arthur A. Levin Ph.D. Distinguished Scientist, Strategic Leader & Director 1954 (70 anos)
Prof. Mark E. Davis Ph.D. Scientific Founder, Member of Scientific Advisory Board and Member of Board of Managers
Mr. John B. Moriarty Jr., ESQ., J.D. Chief Legal Officer & Corporate Secretary 1968 (56 anos)

Endereço: United States, San Diego. CA, 10578 Science Center Drive - abrir no Google Maps, abrir mapas Yandex
Site: https://www.aviditybiosciences.com